Mara Bonelli

3.1k total citations · 1 hit paper
63 papers, 2.5k citations indexed

About

Mara Bonelli is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Mara Bonelli has authored 63 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 32 papers in Molecular Biology and 31 papers in Oncology. Recurrent topics in Mara Bonelli's work include Lung Cancer Treatments and Mutations (21 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and HER2/EGFR in Cancer Research (9 papers). Mara Bonelli is often cited by papers focused on Lung Cancer Treatments and Mutations (21 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and HER2/EGFR in Cancer Research (9 papers). Mara Bonelli collaborates with scholars based in Italy, United Kingdom and Netherlands. Mara Bonelli's co-authors include Roberta Alfieri, Pier Giorgio Petronini, Claudia Fumarola, Andrea Cavazzoni, Silvia La Monica, Maricla Galetti, Daniele Cretella, Angelo F. Borghetti, Marcello Tiseo and Graziana Digiacomo and has published in prestigious journals such as PLoS ONE, The Journal of Physiology and Cancer Research.

In The Last Decade

Mara Bonelli

62 papers receiving 2.5k citations

Hit Papers

Targeting PI3K/AKT/mTOR pathway in non small cell lung ca... 2014 2026 2018 2022 2014 100 200 300

Peers

Mara Bonelli
An Wouters Belgium
Aaron N. Hata United States
David A. Proia United States
Guocan Wang United States
Tobias Otto Germany
Mara Bonelli
Citations per year, relative to Mara Bonelli Mara Bonelli (= 1×) peers Claudia Fumarola

Countries citing papers authored by Mara Bonelli

Since Specialization
Citations

This map shows the geographic impact of Mara Bonelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mara Bonelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mara Bonelli more than expected).

Fields of papers citing papers by Mara Bonelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mara Bonelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mara Bonelli. The network helps show where Mara Bonelli may publish in the future.

Co-authorship network of co-authors of Mara Bonelli

This figure shows the co-authorship network connecting the top 25 collaborators of Mara Bonelli. A scholar is included among the top collaborators of Mara Bonelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mara Bonelli. Mara Bonelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alfieri, Roberta, Claudia Fumarola, Mara Bonelli, et al.. (2024). Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines. Biochemical Pharmacology. 228. 116161–116161. 4 indexed citations
2.
Monica, Silvia La, Federica Vacondio, Alessio Lodola, et al.. (2024). Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models. Scientific Reports. 14(1). 6491–6491. 5 indexed citations
3.
Volta, Francesco, Silvia La Monica, Alessandro Leonetti, et al.. (2023). Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators. Targeted Oncology. 18(6). 953–964. 8 indexed citations
4.
Coccè, Valentina, Mara Bonelli, Silvia La Monica, et al.. (2023). Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma. Biochemical Pharmacology. 214. 115678–115678. 6 indexed citations
5.
Cavazzoni, Andrea, Graziana Digiacomo, Roberta Alfieri, et al.. (2020). Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers. 12(3). 666–666. 36 indexed citations
6.
Digiacomo, Graziana, Claudia Fumarola, Silvia La Monica, et al.. (2020). Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines. Frontiers in Oncology. 10. 563249–563249. 25 indexed citations
7.
Monica, Silvia La, Roberta Minari, Daniele Cretella, et al.. (2019). Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion. Targeted Oncology. 14(5). 619–626. 38 indexed citations
8.
Castelli, Riccardo, Andrea Cavazzoni, Mara Bonelli, et al.. (2018). Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR. European Journal of Medicinal Chemistry. 162. 507–524. 11 indexed citations
9.
Bonelli, Mara, Graziana Digiacomo, Claudia Fumarola, et al.. (2017). Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. Neoplasia. 19(8). 637–648. 82 indexed citations
10.
Bonelli, Mara, Andrea Cavazzoni, Francesca Saccani, et al.. (2015). Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. Molecular Cancer Therapeutics. 14(8). 1916–1927. 32 indexed citations
11.
Galetti, Maricla, Pier Giorgio Petronini, Claudia Fumarola, et al.. (2015). Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines. PLoS ONE. 10(11). e0141795–e0141795. 54 indexed citations
12.
Fumarola, Claudia, Mara Bonelli, Pier Giorgio Petronini, & Roberta Alfieri. (2014). Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer. Biochemical Pharmacology. 90(3). 197–207. 390 indexed citations breakdown →
13.
Alfieri, Roberta, Maricla Galetti, Roberta Andreoli, et al.. (2011). Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines. Molecular Cancer. 10(1). 143–143. 37 indexed citations
14.
Bonelli, Mara, Claudia Fumarola, Roberta Alfieri, et al.. (2010). Synergistic activity of letrozole and sorafenib on breast cancer cells. Breast Cancer Research and Treatment. 124(1). 79–88. 32 indexed citations
15.
Galetti, Maricla, Roberta Alfieri, Andrea Cavazzoni, et al.. (2010). Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines. Biochemical Pharmacology. 80(2). 179–187. 29 indexed citations
16.
Bonelli, Mara, Claudia Fumarola, Roberta Alfieri, et al.. (2008). Anti-proliferative effect of combining Letrozole with Sorafenib in MCF-7/Arom-1 breast cancer cells. Cancer Research. 68. 5441–5441. 1 indexed citations
17.
Bonelli, Mara, Gabriella Cavallini, Alessio Donati, et al.. (2007). Low-level caloric restriction rescues proteasome activity and Hsc70 level in liver of aged rats. Biogerontology. 9(1). 1–10. 27 indexed citations
18.
Alfieri, Roberta, Mara Bonelli, Andrea Cavazzoni, et al.. (2006). Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress. The Journal of Physiology. 576(2). 391–401. 57 indexed citations
19.
Sestili, Piero, Roberta Alfieri, Domenica Carnicelli, et al.. (2004). Shiga toxin 1 and ricin inhibit the repair of H2O2-induced DNA single strand breaks in cultured mammalian cells. DNA repair. 4(2). 271–277. 31 indexed citations
20.
Bonelli, Mara, et al.. (1999). Attenuated Expression of 70-kDa Heat Shock Protein in WI-38 Human Fibroblasts during Aging in Vitro. Experimental Cell Research. 252(1). 20–32. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026